Med-Chemist : "Quintessential Medicinal Chemistry"
Showing posts with label
Accelerated Approval
.
Show all posts
Showing posts with label
Accelerated Approval
.
Show all posts
Monday, June 16, 2025
FDA Grants Accelerated Approval for Vanrafia (atrasentan) for Proteinuria Reduction in Primary IgA Nephropathy
›
Novartis announced the US Food and Drug Administration (FDA) accelerated approval for Vanrafia ® (atrasentan), a potent and selective end...
Thursday, October 3, 2024
FDA Grants Accelerated Approval to Iqirvo (elafibranor) for the Treatment of Primary Biliary Cholangitis
›
Ipsen (Euronext: IPN; ADR: IPSEY) today announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval for Iqir...
Wednesday, September 11, 2024
FDA Grants Accelerated Approval for Rezdiffra (resmetirom) for the Treatment of Patients with Noncirrhotic Nonalcoholic Steatohepatitis (NASH)
›
Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a biopharmaceutical company focused on delivering novel therapeutics for nonalcoholic steatohe...
Thursday, February 15, 2024
FDA Grants Accelerated Approval for Qalsody (tofersen) for the Treatment of Amyotrophic Lateral Sclerosis Associated with a Mutation in the SOD1 Gene
›
Biogen Inc. (Nasdaq: BIIB) announced the U.S. Food and Drug Administration (FDA) approval of Qalsody (tofersen) 100 mg/15mL injection for...
›
Home
View web version
